Fibrin glue mixed with gelatin/hyaluronic acid/chondroitin-6-sulfate tri-copolymer for articular cartilage tissue engineering: The results of real-time polymerase chain reaction

Journal of Biomedical Materials Research - Part A

Volumn 82, Issue 3, 2007, Pages 757-767

  Chou, Cheng Hung ^a,b   Cheng, Winston T K ^c   Kuo, Tzong Fu ^c   Sun, Jui Sheng ^d,e   Lin, Feng Huei ^a,b   Tsai, Jui Che ^a  

^a NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^b NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^c NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^d TAIPEI CITY HOSPITAL   (Taiwan)

^e NATIONAL YANG MING UNIVERSITY   (Taiwan)

Author keywords

Articular cartilage; Fibrin glue; GHC6S; Real time PCR; Tissue engineering

Indexed keywords

ARTICULAR CARTILAGE; CELL DISTRIBUTION; EXTRACELLULAR MATRIX (ECM); FIBRIN GLUE; REAL-TIME PCR;

BIOCOMPATIBILITY; CARTILAGE; GENE EXPRESSION; TISSUE ENGINEERING;

COPOLYMERS;

AGGRECAN; CALCIUM CHLORIDE; CHONDROITIN 6 SULFATE; COLLAGEN TYPE 1; COLLAGEN TYPE 10; COLLAGEN TYPE 2; COPOLYMER; CYTOKINE; DECORIN; FAS ASSOCIATED DEATH DOMAIN PROTEIN; FIBRIN GLUE; FIBRINOGEN; GELATIN; GELATIN HYALURONIC ACID CHONDROITIN 6 SULFATE TRICOPOLYMER; GELATINASE A; HYALURONIC ACID; INTERLEUKIN 1BETA; MATRIX METALLOPROTEINASE 14; PROTEIN S 100; PROTEOGLYCAN; PROTHROMBIN; THROMBIN; TISSUE INHIBITOR OF METALLOPROTEINASE 1; TRANSFORMING GROWTH FACTOR BETA1; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; ARTICULAR CARTILAGE; BIOCOMPATIBILITY; BIOMECHANICS; BONE STRENGTH; CARTILAGE CELL; CARTILAGINOUS TISSUE; CELL CULTURE; CELLULAR DISTRIBUTION; CONTROLLED STUDY; CRYOPRECIPITATION; GENE EXPRESSION REGULATION; IN VITRO STUDY; MATERIALS TESTING; NONHUMAN; NUCLEOTIDE SEQUENCE; PHENOTYPE; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; SWINE; TISSUE ENGINEERING; TISSUE GROWTH; TISSUE REGENERATION;

ANIMALS; CARTILAGE, ARTICULAR; CELL CULTURE TECHNIQUES; CHONDROCYTES; CHONDROITIN SULFATES; EXTRACELLULAR MATRIX; FIBRIN TISSUE ADHESIVE; GELATIN; GENE EXPRESSION PROFILING; HYALURONIC ACID; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SWINE; TISSUE ENGINEERING;

EID: 34547875833     PISSN: 15493296     EISSN: 15524965     Source Type: Journal    
DOI: 10.1002/jbm.a.31186     Document Type: Article

References (43)

1. Hunter W. On the structure and diseases of articulating cartilage. Philos Trans R Soc Lond 1743;470:514-521.
2. Galois L, Freyria AM, Herbage D, Mainard D. Cartilage tissue engineering: State-of-the-art and future approaches. Pathol Biol 2005;53:590-598.
3. Kuo CK, Li WJ, Mauck RL, Tuan RS. Cartilage tissue engineering: Its potential and uses. Curr Opin Rheumatol 2006;18:64-73.
4. Arosarena O. Tissue engineering. Curr Opin Otolaryngol Head Neck Surg 2005;13:233-241.
5. Chou CH, Cheng WTK, Lin CC, Chang CH, Tsai CC, Lin FH. TGF-β1 immobilized tri-co-polymer for articular cartilage tissue engineering. J Biomed Mater Res Part B: Appl Biomater 2006;77B:2:338-348.
6. Chang CH, Liu HC, Lin CC, Chou CH, Lin FH. Gelatin-chondroitin-hyaluronan tri-copolymer scaffold for cartilage tissue engineering. Biomaterials 2003;24:4853-4858.
7. Levangie PK, Norkin CC, Davis FA. Joint Structure and Function: A Comprehensive Analysis, 3rd ed, Philadelpha: F.A. Davis; 2001. pp 49-83.
8. Vunjak-Novakovic G, Obradovic B, Martin I, Bursac PM, Langer R, Freed LE. Dynamic cell seeding of polymer scaffolds for cartilage tissue engineering. Biotechnol Prog 1998;14:193-202.
9. Freed LE, Vunjak-Novakovic G. Cultivation of cell-polymer tissue constructs in simulated microgravity. Biotechnol Bioeng 1995;46:306-313.
10. Vunjak-Novakovic G, Martin I, Obradovic B, Treppo S, Grodzinsky AJ, Langer R, Freed LE. Bioreactor cultivation conditions modulate the composition and mechanical properties of tissue-engineered cartilage. J Orthop Res 1999;17:130-138.
11. Mouw JK, Case ND, Guldberg RE, Plaas AH, Levenston ME. Variations in matrix composition and GAG fine structure among scaffolds for cartilage tissue engineering. Osteoarthritis Cartilage 2005;13:828-836.
12. Park SH, Park SR, Chung SI, Pai KS, Min BH. Tissue-engineered cartilage using fibrin/hyaluronan composite gel and its in vivo implantation. Artif Organs 2005;29:838-845.
13. Silverman RP, Passaretti D, Huang W, Randolph MA, Yaremchuk MJ. Injectable tissue-engineered cartilage using a fibrin glue polymer. Plast Reconstr Surg 1999;103:1809-1818.
14. Frenkel SR, Cesare PED. Scaffolds for articular cartilage repair. Ann Biomed Eng 2004;32:26-34.
15. Lu LP, Zhu X, Valenzuela RG, Currier BL, Yaszemski MJ. Biodegradable polymer scaffolds for cartilage tissue engineering. Clin Orthop Relat Res 2001;391:S251-S270.
16. Peretti GM, Randolph MA, Zaporojan V, Bonassar LJ, Xu JW, Fellers JC, Yaremchuk MJ. A Biomechanical analysis of an engineered cell-scaffold implant for cartilage repair. Ann Plast Surg 2001;46:533-537.
17. Peretti GM, Zaporojan V, Spangenberg KM, Randolph MA, Fellers J, Bonassar LJ. Cell-based bonding of articular cartilage: An extended study. J Biomed Mater Res Part A 2003;64:517-524.
18. Peretti GM, Randolph MA, Villa MT, Buragas MS, Yaremchuk MJ. Cell-based tissue-engineered allogeneic implant for cartilage repair. Tissue Eng 2000;6:567-576.
19. Fortier LA, Nixon AJ, Lust G. Phenotypic expression of equine articular chondrocytes grown in three-dimensional cultures supplemented with supraphysiologic concentrations of insulin-like growth factor-1. Am J Vet Res 2002;63:301-305.
20. Weiss AP, Dorfman HD. S-100 protein in human cartilage lesions. J Bone Joint Surg 1986;68:521-526.
21. Schnabel M, Marlovits S, Eckhoff G, Fichtel I, Gotzen L, Vecsei V, Schlegel J. Dedifferentiation-associated changes in morphology and gene expression in primary human articular chondrocytes in cell culture. Osteoarthritis Cartilage 2002;10:62-70.
22. Holt RG, Cooper J, Denton AM, Hopkins SJ. Cytokine inter-relationships and their association with disease activity in arthritis. Rheumatology 1992;31:725-733.
23. Nicos AN. Guidebook to Cytokines and Their Receptors. New York: Oxford University Press; 1994. p 21.
24. Seibel MJ, Simon PR, John PB. Dynamics of Bone and Cartilage Metabolism. San Diego: Academic Press; 1999. p 139.
25. Lark MW, Bayne EK, Flanagan J, Harper CF, Hoerrner LA, Hutchinson, Hutchinson NI, Singer II, Donatelli SA, Weidner JR, Williams HR, Mumford RA, Lohmander LS. Aggrecan degradation in human cartilage: Evidence for both matrix metalloproteinase and aggrecanase activity in normal, osteoarthritic, and rheumatoid joints. J Clin Invest 1997;100:93-106.
26. Fosang AJ, Last K, Neame PJ, Murphy G, Knauper V, Tschesche H, Hughes CE, Caterson B, Hardingham TE. Neutrophil collagenase (MMP-8) cleaves at the aggrecanase site E373-A374 in the interglobular domain of cartilage aggrecan. Biochem J 1994;304:347-351.
27. Buttner FH, Hughes CE, Margerie D, Lichte A, Tschesche H, Caterson B, Bartnik E. Membrane type 1 matrix metalloproteinase (MT1-MMP) cleaves the recombinant aggrecan substrate rAgglmut at the 'aggrecanase' and the MMP sites: Characterization of MT1-MMP catabolic activities on the interglobular domain of aggrecan. Biochem J 1998;333:159-165.
28. Murphy G, Knauper V. Relating matrix metalloproteinase structure to function: Why the "hemopexin" domain? Matrix Biol 1997;15:511-518.
29. Dinarello CA. Interleukin-1. Cytokine Growth Factor Rev 1997;8:253-265.
30. Sahni A, Guo M, Sahni SK, Francis CW. Interleukin-1β but not IL-1α binds to fibrinogen and fibrin and has enhanced activity in the bound form. Blood 2004;104:409-414.
31. Seibel MJ. Dynamics of Bone and Cartilage Metabolism. San Diego: Academic Press; 1999. p 143, 145.
32. Grander T, Gaissmaier C, Fritz J, Stoop R, Hortschansky P, Mollenhauer J, Aicher WK. Bone morphogenetic protein (BMP)-2 enhances the expression of type II collagen and aggrecan in chondrocytes embedded in alginate beads. Osteoarthritis Cartilage 2004;12:559-567.
33. Marlovits S, Hombauer M, Tamandl D, Vecsei V, Schlegel W. Quantitative analysis of gene expression in human articular chondrocytes in monolayer culture. Int J Mol Med 2004;13:281-287.
34. Girotto D, Urbani S, Brun P, Renier D, Barbucci R, Abatangelo G. Tissue-specific gene expression in chondrocytes grown on three-dimensional hyaluronic acid scaffolds. Biomaterials 2003;24:3265-3275.
35. Kim G, Okumura M, Ishiguro T, Kadosawa T, Fujinaga T. J Vet Med Sci 2003;65:427-430.
36. Kawasaki K, Ochi M, Uchio Y, Adachi N, Matsusaki M. Hyaluronic acid enhances proliferation and chondroitin sulfate synthesis in cultured chondrocytes embedded in collagen gels. J Cell Physiol 1999;179:142-148.
37. Wolff DA, Stevenson S, Golberg VM. S-100 protein immunostaining identifies cells expressing a chondrocyte phenotype during articular cartilage repair. J Orthop Res 1992;10:49-57.
38. Gunther M, Haubeck HD, van de Leur E, Blaser J, Bender S, Gutgemann I, Fischer DC, Tschesche H, Greiling H, Heinrich PC. Transforming growth factor-1 regulates tissue inhibitor of metalloproteinases-1 expression in differentiated human articular chondrocytes. Arthritis Rheum 1994;37:395-405.
39. Frenkel SR, Saadeh PB, Mehrara BJ, Chin GS, Steinbrech DS, Brent B, Gittes GK, Longaker MT. Transforming growth factor β superfamily members: Role in cartilage modeling. Plast Reconstr Surg 2000;105:980-990.
40. Dubois CM, Ruscetti FW, Palaszynski EW, Falk LA, Oppenheim JJ, Keller JR. Transforming growth factor β is a potent inhibitor of interleukin-1 (IL-1) receptor expression: Proposed mechanism of inhibition of IL-1 action. J Exp Med 1990;172:737-744.
41. Harvey AK, Hrubey PS, Chandrasekhar S. Transforming growth factor-β inhibition of interleukin-1 involves down-regulation of interleukin-1 receptors on chondrocytes. Exp Cell Res 1991;195:376-385.
42. Chinnaiyan AM, O'Rourke K, Tewai M, Vishva M, Dixit ADD. A novel death domain-containing protein, interacts with the death domain of Fas and initiates apoptosis. Cell 1995;81:505-512.
43. Lewin B. Genes VII. New York: Oxford University Press; 2000. p 868.